FH and hereditary leiomyomatosis and renal cell cancer: The infrequency of FH-deficient uterine leiomyomas and unique characteristics, such as a genetic link to HLRCC and hereditary leiomyomatosis, already identify the diagnosis and treatment as a unique challenge.